Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in Allogeneic Hematopoietic Stem Cell Transplant Recipients
NCT05554068Phase 2Recruiting
- Sponsor
- Loyola University Chicago
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Loyola University Chicago. Started Mar 2023; status: recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05554068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554068.